Ditchcarbon
  • Contact
  1. Organizations
  2. Geneva Pharmaceuticals Technology Corporation
Public Profile
US
updated 8 months ago

Geneva Pharmaceuticals Technology Corporation Sustainability Profile

Company website

Geneva Pharmaceuticals Technology Corporation, commonly referred to as Geneva Pharmaceuticals, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in the early 2000s, the company has established a strong presence in key operational regions, focusing on the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a commitment to innovation, Geneva Pharmaceuticals offers a diverse portfolio of products, including advanced formulations and delivery systems that set them apart in the market. Their dedication to quality and compliance has earned them a reputable position within the industry, marked by significant milestones in regulatory approvals and product launches. As a trusted partner in healthcare, Geneva Pharmaceuticals continues to contribute to improved patient outcomes through accessible and effective medication solutions.

DitchCarbon Score

How does Geneva Pharmaceuticals Technology Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

45

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Geneva Pharmaceuticals Technology Corporation's score of 45 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Geneva Pharmaceuticals Technology Corporation's reported carbon emissions

Inherited from Sandoz Group AG

Geneva Pharmaceuticals Technology Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sandoz Group AG, and any emissions data or climate commitments would be inherited from this parent organisation. As of now, Geneva Pharmaceuticals has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction targets suggests that the company may still be in the early stages of formalising its climate commitments. Given its affiliation with Sandoz Group AG, any relevant emissions data or climate strategies would be derived from the parent company's initiatives. However, without specific figures or commitments from Sandoz, it is challenging to provide a detailed overview of Geneva Pharmaceuticals' carbon footprint or climate action plans. In summary, while Geneva Pharmaceuticals Technology Corporation is part of a larger corporate family with potential climate initiatives, it currently lacks specific emissions data and reduction commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
75,620,000
00,000,000
00,000,000
00,000,000
Scope 2
158,430,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
0,000,000,000
0,000,000,000

How Carbon Intensive is Geneva Pharmaceuticals Technology Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Geneva Pharmaceuticals Technology Corporation's primary industry is , which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Geneva Pharmaceuticals Technology Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Geneva Pharmaceuticals Technology Corporation is in US, which has a low grid carbon intensity relative to other regions.

Geneva Pharmaceuticals Technology Corporation's Scope 3 Categories Breakdown

Geneva Pharmaceuticals Technology Corporation's Scope 3 emissions, which decreased by 15% last year and decreased by approximately 15% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
69%
Upstream Transportation & Distribution
9%
Use of Sold Products
9%
End-of-Life Treatment of Sold Products
4%
Fuel and Energy Related Activities
3%
Capital Goods
3%
Employee Commuting
2%
Business Travel
<1%
Waste Generated in Operations
<1%
Processing of Sold Products
<1%

Geneva Pharmaceuticals Technology Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Geneva Pharmaceuticals Technology Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Geneva Pharmaceuticals Technology Corporation's Emissions with Industry Peers

Padagis US LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Perrigo

IE
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Sagent Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Innopharma, Inc.

US
•
Research and development services (73)
Updated about 2 months ago

Hospira

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Hikma Labs Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy